The first factor, FGF23, which is increased early in CKD to compensate for the mineral imbalance, contributes directly to CV outcomes through cardiac, vascular, and inflammatory disease [8,9,10,11,12,13,14,15]. Here, FGF23 is linked to chronic kidney disease.